MYCOF - Mydecine Innovations Group Inc. (MYCOF) CEO Josh Bartch on Q4 2020 Results - Earnings Call Transcript
Mydecine Innovations Group Inc. (MYCOF) Q4 2020 Earnings Conference Call May 03, 2021 10:30 AM ET Company Participants Allison Soss - Investor Relations Josh Bartch - Co-founder, Chairman and CEO Dean Ditto - Chief Financial Officer Presentation Operator Greetings, and welcome to the Mydecine Innovations Group Inc. Full Year 2020 Earnings Conference Call. At this time, all participants are in a listen only mode. A question-and-answer session will follow the formal presentation [Operator Instructions]. As a reminder, this conference is being recorded. It is now my pleasure to introduce Allison Soss of Investor Relations. Thank you. You may begin. Allison Soss Thank you, operator. Good morning, everyone and welcome to Mydecine's Full Year 2020 Financial Results Conference Call. Before we begin, I would like to remind you that the comments on today's call will include forward-looking statements, which by their nature involve estimates, projections, goals, forecast and assumptions, and they're
For further details see:
Mydecine Innovations Group Inc. (MYCOF) CEO Josh Bartch on Q4 2020 Results - Earnings Call Transcript